Aiping Zhou: Clinical Trials

9 trials sponsored by Aiping Zhou, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 3 completed, 1 not yet recruiting. 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 29Unknown 5, Completed 3, Not yet recruiting 1

Follow Aiping Zhou: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting
nanocrystalline megestrol acetate combined with ondansetron, dexamethasone combined with ondansetron - Chemotherapy-Induced Nausea and Vomiting (CINV)
Phase 2Not yet recruitingAIPING ZHOU1272025-12-012025-11-24
Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction
Palbociclib, Afatinib - Esophagus Squamous Cell Carcinoma
Phase 2UnknownAIPING ZHOU302023-04-062023-05-18
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
sintilimab, Trastuzumab, S-1 plus oxaliplatin - HER2-positive, Locally Advanced Solid Tumor
Phase 2UnknownAiping Zhou442022-04-012022-04-06
Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients
Fruquintinib and Sintilimab - Colorectal Cancer
Phase 2UnknownAiping Zhou702020-09-012021-01-07
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer
Toripalimab, oxaliplatin, capecitabine - Gastric Cancer Stage II, Gastric Cancer Stage III
Phase 2UnknownAiping Zhou302019-10-082022-03-11
Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer
S-1,Oxaliplatin - S-1 Plus Oxaliplatin
Phase 2UnknownAiping Zhou602016-05-112021-01-05
The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma
Nab-paclitaxel,S-1 - Biliary Tract Cancer
Phase 2CompletedAiping Zhou542016-03-232021-02-01
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
FOLFOXIRI - Locally Advanced Rectal Cancer
Phase 2CompletedAiping Zhou502016-02-062021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
Nab-paclitaxel and S-1 - Advanced Pancreatic Cancer
Phase 2CompletedAiping Zhou322015-05-112021-02-01

Conditions studied

Stomach Neoplasms (2)  ·  Biliary Tract Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Rectal Neoplasms (1)  ·  Vomiting (1)

Interventions

Oxaliplatin (2)  ·  S 1 (combination) (2)  ·  sintilimab (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Afatinib (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Capecitabine (1)  ·  FOLFOXIRI protocol (1)  ·  HMPL-013 (1)  ·  Ondansetron (1)  ·  Tegafur (1)  ·  Trastuzumab (1)  ·  gimeracil (1)  ·  palbociclib (1)  ·  toripalimab (1)

Countries

China (8)

Results publications

PMID 35264150, PMID 37370032